Oxford vaccine trial paused after one illness
Late-stage studies of AstraZeneca's Covid-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot. In a statement on Tuesday evening, the company said it paused vaccination to allow the review of safety data but didn't reveal any information about the possible side effect.
admin 
Late-stage studies of AstraZeneca's Covid-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot. In a statement on Tuesday evening, the company said it paused vaccination to allow the review of safety data but didn't reveal any information about the possible side effect.
